文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Long-Term Impact of Chronic Obstructive Pulmonary Disease and Atrial Fibrillation on Post-Acute Myocardial Infarction Long-Term All-Cause Mortality: Insights from the SAMI III Project.

作者信息

Shiyovich Arthur, Gilutz Harel, Skalsky Keren, Plakht Ygal

机构信息

Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA.

Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva 8410501, Israel.

出版信息

J Clin Med. 2025 Aug 21;14(16):5907. doi: 10.3390/jcm14165907.


DOI:10.3390/jcm14165907
PMID:40869736
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12387317/
Abstract

Chronic obstructive pulmonary disease (COPD) and atrial fibrillation (AF) are common comorbidities in patients with acute myocardial infarction (AMI) and are associated with adverse cardiovascular outcomes. However, the impact of their coexistence on long-term post-AMI outcomes remains unclear. This study aimed to investigate the long-term effects of COPD and AF on AMI survivors. This retrospective cohort study analyzed data from consecutive AMI hospitalizations between 1 January 2002 and 31 October 2017. Patients were categorized into four groups based on the presence or absence of COPD and AF. The primary outcome was all-cause mortality up to 10 years post-discharge. Multivariate survival models were used to assess independent associations. A total of 15,449 AMI survivors (mean age 66 ± 14 years, 30% female) were included, of whom 1386 (8.9%) had COPD, 2547 (16.5%) had AF, and 376 (2.4%) had both conditions. Over a median follow-up of 7.7 (IQR 3.3-10) years, 44.7% of the patients died. COPD (AdjHR = 1.89, 95% CI: 1.74-2.05), AF (AdjHR = 1.39, 95% CI: 1.31-1.48), and coexistence of both conditions (AdjHR = 1.82, 95% CI: 1.61-2.04) were associated with an increased risk for mortality ( < 0.001 for each). However, in patients with both conditions, the mortality risk was comparable to that of COPD alone. While both COPD and AF are associated with increased long-term mortality after AMI, COPD appears to be the primary independent driver of this risk. These findings underscore the need for proactive screening and individualized management in this high-risk population.

摘要

相似文献

[1]
Long-Term Impact of Chronic Obstructive Pulmonary Disease and Atrial Fibrillation on Post-Acute Myocardial Infarction Long-Term All-Cause Mortality: Insights from the SAMI III Project.

J Clin Med. 2025-8-21

[2]
Prescription of Controlled Substances: Benefits and Risks

2025-1

[3]
Immunostimulants versus placebo for preventing exacerbations in adults with chronic bronchitis or chronic obstructive pulmonary disease.

Cochrane Database Syst Rev. 2022-11-14

[4]
Long-acting beta2-agonist in addition to tiotropium versus either tiotropium or long-acting beta2-agonist alone for chronic obstructive pulmonary disease.

Cochrane Database Syst Rev. 2015-10-22

[5]
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.

Health Technol Assess. 2008-6

[6]
Self-management interventions for people with chronic obstructive pulmonary disease.

Cochrane Database Syst Rev. 2022-1-10

[7]
Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease.

Cochrane Database Syst Rev. 2014-3-10

[8]
Curative catheter ablation in atrial fibrillation and typical atrial flutter: systematic review and economic evaluation.

Health Technol Assess. 2008-11

[9]
Dietary Approaches to Stop Hypertension (DASH) for the primary and secondary prevention of cardiovascular diseases.

Cochrane Database Syst Rev. 2025-5-6

[10]
Tiotropium versus long-acting beta-agonists for stable chronic obstructive pulmonary disease.

Cochrane Database Syst Rev. 2012-9-12

本文引用的文献

[1]
Analysis of risk factors and development of predictive model for acute myocardial injury in patients with acute exacerbation of chronic obstructive pulmonary disease.

J Thorac Dis. 2025-4-30

[2]
Cardiovascular Risk in Patients with Chronic Obstructive Pulmonary Disease: A Systematic Review.

J Clin Med. 2024-8-31

[3]
Exacerbation History and Risk of Myocardial Infarction and Pulmonary Embolism in COPD.

Chest. 2024-12

[4]
Lipoprotein(a) as a cardiovascular risk factor among patients with and without diabetes Mellitus: the Mass General Brigham Lp(a) Registry.

Cardiovasc Diabetol. 2024-7-18

[5]
Effects of mineralocorticoid receptor antagonists on new-onset or recurrent atrial fibrillation: a Bayesian and frequentist network meta-analysis of randomized trials.

Curr Probl Cardiol. 2024-9

[6]
In-hospital outcomes and postdischarge mortality in patients with acute coronary syndrome and atrial fibrillation.

Heart Rhythm. 2024-9

[7]
β-Blocker Use and Clinical Outcomes in Patients With COPD Following Acute Myocardial Infarction.

JAMA Netw Open. 2024-5-1

[8]
Early Detection of Atrial Fibrillation in Chronic Obstructive Pulmonary Disease Patients.

Medicina (Kaunas). 2024-2-20

[9]
Risk of Death and Cardiovascular Events in Asian Patients With Atrial Fibrillation and Chronic Obstructive Pulmonary Disease: A Report From the Prospective APHRS Registry.

J Am Heart Assoc. 2024-4-2

[10]
Impact of chronic obstructive pulmonary disease in patients with atrial fibrillation: an analysis from the GLORIA-AF registry.

Europace. 2023-12-28

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索